119-HR-3164 DC Insider Prediction Analysis

Passage probability

Read on as a street‑level forecast from a Hill vote‑counter’s lens — not advocacy. The bill has momentum after markup, but its fate hinges on Senate bandwidth and stakeholder crossfire. [1]House Committee on Ways and Means — Ways & Means markup page for May 21, 2026 —…

• House pathway: On May 21, 2026, Ways & Means ordered H.R. 3164 favorably reported by voice vote, adopting a Chairman’s substitute that rebrands it the “Main Street Pharmacy Access Act.” That is a textbook green‑light for the Floor once the score and pay‑for are squared. [1]House Committee on Ways and Means — Ways & Means markup page for May 21, 2026 —…
• Key text shifts in the substitute lower near‑term budget friction: implementation moved from January 1, 2026 to January 1, 2028 and the bill taps the Medicare Improvement Fund (reduced to $0) as the offset; the 100% payment modifier for PHE‑related services is struck, leaving the base at 85% of the physician fee schedule. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Chamber control context: Republicans hold narrow control of the House in the 119th Congress; the Senate is under Republican management with John Thune as Majority Leader — dynamics that generally ease House passage but do not waive the Senate’s 60‑vote cloture reality for a stand‑alone bill. [3]PolitiFact — The 119th Congress: House and Senate majorities overview
• Senate pathway: The companion (S. 2426) sits in Senate Finance with no reported action to date; success likely requires packaging (e.g., health “extenders”) or unanimous‑consent clearance, given floor time pressures. [4]Congress.gov — S. 2426 (ECAPS Act) — All Information (Except Text); referred to…

Obstacles

• Organized physician opposition: Major medical societies have filed coalition letters against pharmacist billing under Part B, a signal for Senate resistance and amendment pushes. [5]Massachusetts Medical Society (hosting coalition letter) — AMA‑led coalition le…
• Senate floor time and the 60‑vote hurdle: With a crowded calendar and election‑year positioning, a stand‑alone UC or time‑agreement isn’t guaranteed; absent that, it needs a 60‑vote path or a larger health package. (Majority‑leader control context cited above.) [6]U.S. Senate — U.S. Senate — Majority and Minority Leaders (historical and curre…
• Inter‑committee coordination: The bill has House dual referral (Energy & Commerce; Ways & Means). While W&M advanced it, E&C activity has been hearings and stakeholder records to date; any discrepancy in pacing or jurisdictional edits can slow the rule. [7]NCPA — House E&C Health Subcommittee hearing note on access to Medicare service…
• Budget mechanics: Although the Chairman’s substitute deploys a Medicare Improvement Fund reduction to offset costs, CBO scoring and any downstream “pay‑for cleanup” can still delay the floor or force further tweaks. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• State‑law gating: The bill’s coverage keys off services pharmacists are authorized to perform under state law, creating variation that some senators may flag as an implementation risk. [8]Congress.gov / GPO — H.R. 3164 introduced text (PDF) — Ensuring Community Acces…

Short‑term consequences (next 1–2 quarters)

• If it advances to a House vote: Expect bipartisan messaging around rural access and ER decompression; pharmacy groups will amplify committee momentum; physician groups will press for guardrails or narrowing amendments. [9]American Pharmacists Association — APhA press release applauding Ways & Means a…
• If it stalls: Advocates will pivot to packaging strategies (extenders/omnibus) while keeping Senate Finance staff engaged; the rename and delayed start make it easier to tuck into a broader health vehicle. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Policy signaling effect immediately: Even before enactment, committee action cues CMS and MACs on likely coding/billing contours (E/M framing at 85% of the physician fee schedule) for implementation planning. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…

Long‑term consequences (if enacted)

• Medicare benefit design: Part B would recognize specified pharmacist services as covered when state law allows and required collaboration/supervision conditions are met, with balance‑billing barred. [8]Congress.gov / GPO — H.R. 3164 introduced text (PDF) — Ensuring Community Acces…
• Access and site‑of‑care shift: Pharmacies become a predictable point of care for test‑and‑treat of flu, COVID‑19, RSV, and strep, plus PHE‑related conditions designated by HHS — potentially reducing low‑acuity ED and urgent‑care load. [8]Congress.gov / GPO — H.R. 3164 introduced text (PDF) — Ensuring Community Acces…
• Budget/utilization: Delayed start (2028) smooths the near‑term score; over time, utilization rises where state scope is broad, while narrower states see limited uptake — a variability Congress intentionally left to state practice acts. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Political coalitions: Durable support from retail and health‑system pharmacy groups and PBM groups on access grounds; recurring pushback from organized medicine likely shifts to oversight and implementation fights post‑enactment. [9]American Pharmacists Association — APhA press release applauding Ways & Means a…

Forecast

1. Base case (most likely): House passage on a bipartisan vote in summer or folded into an autumn health package; Senate action contingent on packaging — enactment odds ~40% this Congress. [1]House Committee on Ways and Means — Ways & Means markup page for May 21, 2026 —…
2. Upside case: Coupled with other bipartisan Medicare items and cleared by unanimous consent or time agreement in the Senate; enactment odds rise to ~55%. [4]Congress.gov — S. 2426 (ECAPS Act) — All Information (Except Text); referred to…
3. Downside case: Senate calendar plus physician‑group resistance force deferral; measure becomes a marker for the next Congress with committee groundwork preserved. [5]Massachusetts Medical Society (hosting coalition letter) — AMA‑led coalition le…

Procedural note: As a stand‑alone authorization that modifies Medicare Part B, this is outside reconciliation scope absent a budget vehicle; most efficient path is packaging with extenders where bipartisan support and offset conventions already exist. The Chairman’s substitute (new 2028 start; Medicare Improvement Fund reduction) is crafted with that path in mind. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…

What the bill does now (post‑markup snapshot)

• Renames the bill “Main Street Pharmacy Access Act.” [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Covers pharmacist services under Medicare Part B when authorized by state law and furnished with required collaboration/supervision, aligning with services that would otherwise be covered if furnished by a physician. [8]Congress.gov / GPO — H.R. 3164 introduced text (PDF) — Ensuring Community Acces…
• Defines covered pharmacist encounters as E/M‑category visits for testing or treatment of COVID‑19, influenza, RSV, or strep throat, plus conditions tied to a declared PHE (as determined by HHS). [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Sets payment at 85% of the physician fee schedule; removes earlier draft’s 100% payment for PHE‑related services; bars balance billing. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Delays applicability to items and services furnished on or after January 1, 2028. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…
• Offsets costs by reducing the Medicare Improvement Fund to $0. [2]House Committee on Ways and Means — H.R. 3164 Green Sheet — Chairman’s Amendmen…

Context and positions

• Current law context: Pharmacists are not recognized as Part B “physicians” and generally cannot bill Part B for E/M services absent specific statutory authority — H.R. 3164 would add pharmacist services to §1861(s)(2). [10]SSA / HHS — Social Security Act §1861 definitions (context for Part B provider…
• Support: Pharmacy groups (APhA, NACDS, ASHP, ACCP, others) applauded committee passage on May 21, 2026 and frame the bill as access‑expanding. [9]American Pharmacists Association — APhA press release applauding Ways & Means a…
• Opposition: An AMA‑led coalition opposes expanding pharmacist‑billable services under Part B, foreshadowing asks for tighter scope or supervision language. [5]Massachusetts Medical Society (hosting coalition letter) — AMA‑led coalition le…
• Process status: House Ways & Means favorably reported the bill as amended by voice vote on May 21, 2026; Senate companion (S. 2426) is in Senate Finance. [1]House Committee on Ways and Means — Ways & Means markup page for May 21, 2026 —…
• Institutional control: Republicans narrowly control the House; Republicans control the Senate (Majority Leader John Thune), shaping agenda control and floor time. [3]PolitiFact — The 119th Congress: House and Senate majorities overview